Zynerba (ZYNE) stock forecast for 2025. Forecast tables and graphs.

Zynerba (ZYNE) stock forecast for 2025

The forecast has been updated: June 10, 2021 7:37


Zynerba stock price online today

Analyst Target Price

7.63

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Zynerba stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? Zynerba stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $7.63 target price for Zynerba stock stock.

Today 200 Day Moving Average is the support level (4.4327 $).

50 Day Moving Average is the support level (4.6486 $).




ZYNE Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 9.64 8.58 10.21 15.97 %
Feb 9.76 8.91 10.64 16.18 %
Mar 10.90 9.82 12.08 18.68 %
Apr 11.00 9.87 12.01 17.81 %
May 12.94 11.07 14.26 22.37 %
Jun 12.82 12.08 13.79 12.38 %
Jul 13.61 11.99 14.27 15.96 %
Aug 13.95 12.57 14.70 14.52 %
Sep 14.48 12.73 16.35 22.15 %
Oct 15.65 14.80 17.06 13.21 %
Nov 16.58 15.14 18.67 18.86 %
Dec 17.29 16.17 18.07 10.51 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Zynerba stock.


Zynerba overview

Zynerba Address

80 West Lancaster Avenue, Devon, PA, United States, 19333

Market Capitalization

231 833 424 $

EBITDA

-36 895 716

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-1.892

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

0

Forward PE

0

EV To Revenue

397.6066

EV To EBITDA

0

52 Week High

9

52 Week Low

3.12

50 Day Moving Average

4.6486

200 Day Moving Average

4.4327

Shares Outstanding

41251500

Shares Float

39132584

Shares Short Prior Month

3495333

Short Ratio

2.25

Percent Insiders

2.604

Percent Institutions

32.242

Zynerba stock forecast for this year


Zynerba stock forecast for Jan 2025.
Estimated Average Forecasted Zynerba Price: 9.64. Positive monthly dynamics of the instrument is expected with 15.971% volatility is expected.

Pessimistic forecast: 8.58

Optimistic: 10.21


Zynerba stock forecast for Feb 2025.
Estimated Average Forecasted Zynerba Price: 9.76. Positive monthly dynamics of the instrument is expected with 16.183% volatility is expected.

Pessimistic forecast: 8.91

Optimistic: 10.64


Zynerba stock forecast for Mar 2025.
Estimated Average Forecasted Zynerba Price: 10.90. Positive monthly dynamics of the instrument is expected with 18.683% volatility is expected.

Pessimistic forecast: 9.82

Optimistic: 12.08


Zynerba stock forecast for Apr 2025.
Estimated Average Forecasted Zynerba Price: 11.00. Positive monthly dynamics of the instrument is expected with 17.806% volatility is expected.

Pessimistic forecast: 9.87

Optimistic: 12.01


Zynerba stock forecast for May 2025.
Estimated Average Forecasted Zynerba Price: 12.94. Positive monthly dynamics of the instrument is expected with 22.366% volatility is expected.

Pessimistic forecast: 11.07

Optimistic: 14.26


Zynerba stock forecast for Jun 2025.
Estimated Average Forecasted Zynerba Price: 12.82. Negative monthly dynamics of the instrument is expected with 12.384% volatility is expected.

Pessimistic forecast: 12.08

Optimistic: 13.79


Zynerba stock forecast for Jul 2025.
Estimated Average Forecasted Zynerba Price: 13.61. Positive monthly dynamics of the instrument is expected with 15.964% volatility is expected.

Pessimistic forecast: 11.99

Optimistic: 14.27


Zynerba stock forecast for Aug 2025.
Estimated Average Forecasted Zynerba Price: 13.95. Positive monthly dynamics of the instrument is expected with 14.517% volatility is expected.

Pessimistic forecast: 12.57

Optimistic: 14.70


Zynerba stock forecast for Sep 2025.
Estimated Average Forecasted Zynerba Price: 14.48. Positive monthly dynamics of the instrument is expected with 22.149% volatility is expected.

Pessimistic forecast: 12.73

Optimistic: 16.35


Zynerba stock forecast for Oct 2025.
Estimated Average Forecasted Zynerba Price: 15.65. Positive monthly dynamics of the instrument is expected with 13.211% volatility is expected.

Pessimistic forecast: 14.80

Optimistic: 17.06


Zynerba stock forecast for Nov 2025.
Estimated Average Forecasted Zynerba Price: 16.58. Positive monthly dynamics of the instrument is expected with 18.863% volatility is expected.

Pessimistic forecast: 15.14

Optimistic: 18.67


Zynerba stock forecast for Dec 2025.
Estimated Average Forecasted Zynerba Price: 17.29. Positive monthly dynamics of the instrument is expected with 10.507% volatility is expected.

Pessimistic forecast: 16.17

Optimistic: 18.07



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 110.48 (14.06.2021) 0.52 %
AbbVie Inc.
ABBV 115.4 (14.06.2021) -0.02 %
Aeterna Zentaris Inc.
AEZS 1.02 (14.06.2021) -2.86 %
Allakos Inc.
ALLK 90.87 (14.06.2021) -3.24 %
Allogene Therapeutics, Inc.
ALLO 25.37 (14.06.2021) -2.80 %
Amgen Inc.
AMGN 241.19 (14.06.2021) -0.65 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.66 (14.06.2021) 1.81 %
Aurora Cannabis Inc.
ACB 9.67 (14.06.2021) -1.53 %
Becton Dickinson and Company
BDX 242.72 (14.06.2021) 0.03 %
Biogen Inc.
BIIB 406.14 (14.06.2021) 2.40 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 100.4 (14.06.2021) -4.40 %
BioNTech SE
BNTX 220.58 (14.06.2021) -7.53 %
bluebird bio, Inc.
BLUE 33.53 (14.06.2021) -1.67 %
Boston Scientific Corp.
BSX 42.54 (14.06.2021) -0.86 %
Bristol-Myers Squibb Company
BMY 67.29 (14.06.2021) -0.07 %
Canopy Growth Corp.
CGC 25.14 (14.06.2021) -2.82 %
Castle Biosciences, Inc.
CSTL 71.86 (14.06.2021) -0.04 %
Eli Lilly and Company
LLY 226.1 (14.06.2021) 0.90 %
Emergent BioSolutions Inc.
EBS 61.79 (14.06.2021) -2.71 %
Exelixis, Inc.
EXEL 22.76 (14.06.2021) -0.96 %
G1 Therapeutics, Inc.
GTHX 22.75 (14.06.2021) 5.23 %
Gilead Sciences, Inc.
GILD 68.15 (14.06.2021) -0.90 %
GlaxoSmithKline plc
GSK 40.49 (14.06.2021) 0.85 %
GoodRx Holdings, Inc.
GDRX 38.33 (14.06.2021) 4.21 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 82.64 (14.06.2021) 0.07 %
Inovio Pharmaceuticals, Inc.
INO 8.91 (14.06.2021) -2.09 %
Johnson & Johnson
JNJ 165.37 (14.06.2021) 0.25 %
Medtronic plc.
MDT 124.15 (14.06.2021) 0.30 %
Merck & Co., Inc.
MRK 75.45 (14.06.2021) -1.08 %
Moderna, Inc.
MRNA 207.41 (14.06.2021) -5.23 %
Novartis AG
NVS 93.59 (14.06.2021) 0.97 %
Novavax, Inc.
NVAX 207.71 (14.06.2021) -0.94 %
ObsEva SA
OBSV 3.17 (14.06.2021) -0.63 %
OrganiGram Holdings Inc.
OGI 3.14 (14.06.2021) -1.26 %
Pfizer Inc.
PFE 39.63 (14.06.2021) -1.30 %
Regeneron Pharmaceuticals, Inc.
REGN 528.75 (14.06.2021) 0.61 %
Sanofi
SNY 54.25 (14.06.2021) 0.84 %
Schrodinger, Inc.
SDGR 76.34 (14.06.2021) -1.51 %
Senseonics Holdings, Inc.
SENS 3.96 (14.06.2021) -1.25 %
Sorrento Therapeutics, Inc.
SRNE 9.46 (14.06.2021) 6.65 %
Stryker Corp.
SYK 255.69 (14.06.2021) -0.04 %
Sundial Growers Inc.
SNDL 1.06 (14.06.2021) 0.95 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 11.05 (14.06.2021) -0.54 %
Thermo Fisher Scientific Inc.
TMO 470.07 (14.06.2021) 1.06 %
Tilray, Inc.
TLRY 19.16 (14.06.2021) -3.67 %
UnitedHealth Group, Inc.
UNH 399.16 (14.06.2021) 0.32 %
Veeva Systems Inc.
VEEV 303.9 (14.06.2021) 1.57 %
Zomedica Corp.
ZOM 0.9458 (14.06.2021) -0.08 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.66 (14.06.2021) 0.35 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.